INFOGRAPHIC: Scientific Advancements: Next-Generation ETs in ER+, HER2-, ABC
This infographic provides an overview of the approved and investigational ET classes in ER+, HER2-, ABC; highlights the potential benefits of next-generation ETs, resulting in more potent endocrine pathway antagonism
Date of Last Review: March 28, 2024
Are you satisfied with this content?